BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 19, 2016
View Archived Issues
Daiichi Sankyo reviews events of fourth quarter of fiscal 2015
Read More
Ono Pharmaceutical enters into option agreement with IDAC Theranostics for IT-1208
Read More
Theranexus presents promising results for TNH-102 in excessive daytime sleepiness
Read More
Patient-derived models could facilitate discovery of drugs for NSCLC harboring exon-20 insertions
Read More
Novel experimental mouse models of Brazilian Zika virus infection
Read More
Evestra describes first-in-class leukemia inhibitory factor inhibitor
Read More
Novel, dual IDO1/TDO inhibitor RG-70099 is active in vivo
Read More
PfSPZ Vaccine provides durable protection against malaria
Read More
Indivior announces dopamine receptor inhibitors
Read More
Genoscience Pharma patents antineoplastic compounds
Read More
Pfizer presents TRPA1 antagonists
Read More
Merck & Co. announces ROMK channel blockers
Read More
Karus Therapeutics introduces histone deacetylase inhibitors
Read More
Agios and Celgene form new metabolic immuno-oncology collaboration
Read More
Merck & Co. initiates phase I study of MK-4280 in patients with advanced solid tumors
Read More
Oramed's phase IIb trial of ORMD-0801 meets primary endpoints
Read More
ANAVEX 2-73 reduces epileptic spasms in infant rats
Read More
FDA approves Tecentriq and complementary diagnostic for metastatic urothelial carcinoma
Read More
Monaleesa-2 trial of ribociclib achieves meaningful improvement in PFS
Read More
Lynparza does not achieve primary OS endpoint in phase III GOLD trial
Read More
Phase I cohort results for mirvetuximab soravtansine in FRalpha-positive ovarian cancer
Read More
Novartis creates two new divisions, Novartis Pharmaceuticals and Novartis Oncology
Read More
GeoVax Labs plans new trial of HIV vaccine GOVX-B11
Read More
Gilead Sciences completes acquisition of Nimbus Apollo
Read More